Advertisement
Screener

FOXO TECHNOLOGIES INC. (FOXO) APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

2.5 / 5 stars · 14/28 Roast Me

FOXO TECHNOLOGIES INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition

FOXO TECHNOLOGIES INC. (FOXO) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $103.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-28.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital

us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2024-06-28

  • FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-03-31 was $103.00K, a 88.57% decline year-over-year.
  • FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-03-31 was $901.00K.
  • FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-12-31 was -$1.00K.
  • FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-09-30 was $211.00K.
  • FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $716.00K.
Period endAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month
2024-03-31$103.00K
10-Q · filed 2024-06-28
2023-03-31$901.00K
10-Q · filed 2024-06-28
$900.00K
derived: sum of 2 quarters · filed 2024-06-28
$1.11M
derived: sum of 3 quarters · filed 2024-06-28
2022-12-31-$1.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06
$210.00K
derived: sum of 2 quarters · filed 2024-06-06
$716.00K
10-K · filed 2024-06-06
2022-09-30$211.00K
10-Q/A · filed 2024-06-04
$717.00K
10-Q/A · filed 2024-06-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
iSpecimen Inc. (ISPC)United States$0.003B
OneMedNet Corp (ONMD)$0.042B
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14